0000899243-19-013252.txt : 20190513
0000899243-19-013252.hdr.sgml : 20190513
20190513170058
ACCESSION NUMBER: 0000899243-19-013252
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190509
FILED AS OF DATE: 20190513
DATE AS OF CHANGE: 20190513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Richard King Mellon Foundation
CENTRAL INDEX KEY: 0001774767
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38886
FILM NUMBER: 19819176
BUSINESS ADDRESS:
STREET 1: P.O. BOX 945
CITY: LIGONIER
STATE: PA
ZIP: 15658
BUSINESS PHONE: 724-238-8466
MAIL ADDRESS:
STREET 1: P.O. BOX 945
CITY: LIGONIER
STATE: PA
ZIP: 15658
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trevi Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563880
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450834299
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-304-2499
MAIL ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-05-09
1
0001563880
Trevi Therapeutics, Inc.
TRVI
0001774767
Richard King Mellon Foundation
C/O TREVI THERAPEUTICS, INC.
195 CHURCH STREET, 14TH FLOOR
NEW HAVEN
CT
06510
0
0
1
0
Common Stock
2019-05-09
4
C
0
222816
A
222816
D
Common Stock
2019-05-09
4
J
0
24341
0.00
A
247157
D
Common Stock
2019-05-09
4
P
0
100000
10.00
A
347157
D
Series C Preferred Stock
2019-05-09
4
C
0
1908450
0.00
D
Common Stock
222816
0
D
On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Consists of shares transferred to Richard King Mellon Foundation by TPG Biotechnology Partners III, L.P. in connection with the closing of the Issuer's initial public offering.
/s/ Douglas L. Sisson, Vice President and Treasurer
2019-05-09